<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>Molecular Diversity Preservation International</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M651</article-id>
      <article-id pub-id-type="publisher-id">molbank-2010-M651</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>2-[4-[Bis(2-chloroethyl)amino]benzyl]-5,5-dimethyl-2,5-dihydro-4H-benzo[e]isoindol-4-one (Cytotoxic Oxonaphthalene-Pyrroles, Part I)</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Spreitzer</surname>
            <given-names>Helmut</given-names>
          </name>
          <xref rid="c1-molbank-2010-M651" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Puschmann</surname>
            <given-names>Christiane</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2010-M651">Department of Drug and Natural Product Synthesis, Faculty of Life Sciences, University of Vienna, Althanstra&#xDF;e 14, A- 1090 Vienna, Austria</aff>
      <author-notes>
        <corresp id="c1-molbank-2010-M651"><label>*</label>Author to whom correspondence should be addressed; E-Mail: <email>helmut.spreitzer@univie.ac.at</email>.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>22</day>
        <month>01</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>03</month>
        <year>2010</year>
      </pub-date>
      <volume>2010</volume>
      <issue>1</issue>
      <elocation-id>M651</elocation-id>
      <history>
        <date date-type="received">
          <day>04</day>
          <month>12</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>01</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2010 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland.</copyright-statement>
        <copyright-year>2010</copyright-year>
        <license>
          <p>This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>A bis(chloroethyl)amine containing side chain is attached to an oxonaphthalene-annelated pyrrol in expectation of DNA alkylating properties. The cytotoxicity is evaluated against two cell lines, KB-31 and KB-8511, respectively.</p>
      </abstract>
      <kwd-group>
        <kwd>pyrrole</kwd>
        <kwd>DNA-alkylation</kwd>
        <kwd>anticancer</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1-molbank-2010-M651" sec-type="intro">
      <title>1. Introduction</title>
      <p>Nitrogen mustards were the first clinically effective cancer therapeutic agents. Chlorambucil and melphalan are two of numerous aromatic derivatives of compounds with a nitrogen mustard moiety that have been synthesized. They have been a clinical agent for many years and remains in common use at the present time. The cytotoxic effects are based on the highly active aziridinium cation intermediates arising from the bis(2-chloroethyl)amine moiety [<xref ref-type="bibr" rid="B1-molbank-2010-M651">1</xref>]. In continuation of our department&#x2019;s previous studies in the field of antitumor agents [<xref ref-type="bibr" rid="B2-molbank-2010-M651">2</xref>,<xref ref-type="bibr" rid="B3-molbank-2010-M651">3</xref>,<xref ref-type="bibr" rid="B4-molbank-2010-M651">4</xref>,<xref ref-type="bibr" rid="B5-molbank-2010-M651">5</xref>,<xref ref-type="bibr" rid="B6-molbank-2010-M651">6</xref>,<xref ref-type="bibr" rid="B7-molbank-2010-M651">7</xref>,<xref ref-type="bibr" rid="B8-molbank-2010-M651">8</xref>] we are reporting in this paper the synthesis of the oxonaphthalene annelated pyrrole <bold>3</bold> with an attached side chain containing a bis(2-chloroethyl)amine group. The cytotoxic activity of <bold>3</bold> was evaluated.</p>
    </sec>
    <sec id="sec2-molbank-2010-M651" sec-type="results">
      <title>2. Results and Discussion </title>
      <p>As previously published the N-alkylation of <bold>1</bold> [<xref ref-type="bibr" rid="B9-molbank-2010-M651">9</xref>,<xref ref-type="bibr" rid="B10-molbank-2010-M651">10</xref>] with BOC-protected 4-aminobenzyl bromide with NaH in DMF afforded selectively <bold>2</bold> [<xref ref-type="bibr" rid="B8-molbank-2010-M651">8</xref>], following deprotection with trifluoroacetic acid [<xref ref-type="bibr" rid="B11-molbank-2010-M651">11</xref>] furnished the amine which was treated with ethylene oxide [<xref ref-type="bibr" rid="B4-molbank-2010-M651">4</xref>]. The resulting diol was converted via its mesylate and subsequent reaction with LiCl [<xref ref-type="bibr" rid="B12-molbank-2010-M651">12</xref>] to target compound <bold>3</bold>. The biological activity of <bold>3</bold> was tested against two cancer cell lines, KB-31 and KB-8511, respectively. KB-31 is a drug sensitive human epidermoid cell line, whereas KB-8511 is a multi drug resistant subline typically overexpressing P-glycoprotein. The IC<sub>50</sub>[&#x3BC;M] values of <bold>3</bold> are &gt;10.00 (KB-31) and 7.138 (KB-8511), respectively [for experimental details see[<xref ref-type="bibr" rid="B13-molbank-2010-M651">13</xref>,<xref ref-type="bibr" rid="B14-molbank-2010-M651">14</xref>]).</p>
	  <p><disp-formula>
<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M651-i001.tif"/>
</disp-formula></p>
    </sec>
    <sec id="sec3-molbank-2010-M651" sec-type="methods">
      <title>3. Experimental</title>
      <sec id="sec3dot1-molbank-2010-M651">
        <title>3.1. 2-[4-[Bis(2-chloroethyl)amino]benzyl]-5,5-dimethyl-2,5-dihydro-4H-benzo[e]isoindol-4-one <italic>(<bold>3</bold>)</italic> </title>
        <p>(a) To a solution of <bold>2</bold> [<xref ref-type="bibr" rid="B8-molbank-2010-M651">8</xref>] (1.07 g, 2.56 mmol) in 11.7 mL of dry CH<sub>2</sub>Cl<sub>2</sub> were added dropwise under argon 2.3 mL (30.25 mmol) of triflouroacetic acid. After stirring for 2 h at room temperature the reaction mixture was concentrated under vacuum and the residue was dissolved in ethyl acetate. The organic phase was washed with aqueous NaHCO<sub>3</sub>-solution and brine, dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated. </p>
        <p>(b) The resulting crude product was purified by column chromatography (aluminium oxide, light petro&#xAD;leum/ethyl acetate, 60/40) to afford a solid residue which was dissolved in 25 mL of EtOH/H<sub>2</sub>O (3/1). 0.55 mL (0.61 g, 1.40 mmol) of oxirane were added to the reaction mixture at 0 <sup>o</sup>C. After heating for 12 h under reflux the reaction mixture was concentrated under vacuum and the residue was dissolved in ethyl acetate. The organic phase was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated. The resulting crude product was used for the next reaction step without further purification. </p>
        <p>(c) To a solution of the obtained crude product in 5.5 mL of dry CH<sub>2</sub>Cl<sub>2</sub> and 0.5 mL of triethylamine were added dropwise under argon 0.23 mL (2.90 mmol) of methanesulfonicacid chloride. After stirring for 15 min the reaction mixture was washed with H<sub>2</sub>O, dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under vacuum. The residue was dissolved in 5.0 mL DMF and after addition of 0.9 g LiCl (21.5 mmol; dried over P<sub>2</sub>O<sub>5</sub> at 100 <sup>o</sup>C for 12 h) the reaction mixture was heated for 5 min at 120 <sup>o</sup>C. The cooled reaction mixture was diluted with H<sub>2</sub>O and extracted with ethyl acetate. The combined organic layers were washed with H<sub>2</sub>O, dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated. The crude product was purified by column chromatography (silica gel, light petroleum/ethyl acetate 60/40 + 0.3% TEA) to afford 112 mg (11%) of <bold>3</bold>. M.p. 50-52 <sup>o</sup>C (light petroleum/ethyl acetate). IR (KBr): 1654, 1615, 1523, 1353, 1148. MS (EI, 70 eV) <italic>m/z</italic>: 442 (M<sup>+</sup> + 2, 2), 440 (M<sup>+</sup>, 3), 234 (11), 232 (66), 231 (14), 230 (100), 118 (58), 63 (9). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 200 MHz) = 7.53 (m, 1H, 9-H), 7.43 (m, 1H, 6-H), 7.38 (d, <italic>J</italic> = 2.0 Hz, 1H, 3-H), 7.21 (m, 2H, 7-H, 8-H), 7.14 (d, <italic>J</italic> = 8.8 Hz, 2H, 2<sub>phenyl</sub>-H, 6<sub>phenyl</sub>-H), 7.0 (d, <italic>J</italic> = 2.0 Hz, 1H, 1-H), 6.65 (d, <italic>J</italic> = 8.8 Hz, 2H, 3<sub>phenyl</sub>-H, 5<sub>phenyl</sub>-H), 5.0 (s, 2H, NCH<sub>2</sub>), 3.71 (m, 4H, 2 &#xD7; C<underline>H</underline><sub>2</sub>CH<sub>2</sub>Cl), 3.64 (m, 4H, 2 &#xD7; CH<sub>2</sub>C<underline>H</underline><sub>2</sub>Cl), 1.51 (s, 6H, (CH<sub>3</sub>)<sub>2</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 50 MHz) = 198.4 (C-4), 146.1 (C<sub>phenyl</sub>-4), 144.1 (C-5a), 129.5 (C<sub>phenyl</sub>-2, C<sub>phenyl</sub>-6), 127.0 (C-6), 126.9 (C-9a), 126.6 (C-7), 126.1 (C-8), 125.3/124.5 (C<sub>phenyl</sub>-1, C-9b), 123.3 (C-3), 122.6 (C-9), 118.3 (C-3a), 115.0 (C-1), 112.1 (C<sub>phenyl</sub>-3, C<sub>phenyl</sub>-5), 53.7/53.3 (NCH<sub>2</sub>, 2 &#xD7; <underline>C</underline>H<sub>2</sub>CH<sub>2</sub>Cl), 47.6 (C-5), 40.2 (2 &#xD7; CH<sub>2</sub>Cl), 28.1 ((CH<sub>3</sub>)<sub>2</sub>). HRMS calc. for C<sub>25</sub>H<sub>26</sub>N<sub>2</sub>OCl<sub>2</sub>: 440.1422. Found: 440.1425. </p>
      </sec>
    </sec>
  </body>
  <back>
    <app-group>
    <app id="app1-molbank-2010-M651">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2010-M651-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M651-s001-mod.mol">
   <label>Supplementary File 1</label>
</supplementary-material>
        <supplementary-material id="molbank-2010-M651-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M651-s001.mol">
   <label>Supplementary File 2</label>
</supplementary-material>
    </app>
	</app-group>
	<ack>
      <title>Acknowledgement</title>
      <p>We are indepted to Novartis AG (Vienna, Austria) for the evaluation of the cytotoxic activity.</p>
    </ack>
    <ref-list>
      <title>References and Notes</title>
      <ref id="B1-molbank-2010-M651">
        <label>1.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Montgomery</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <source>Cancer Chemotherapeutic Agents, ACS Professional Reference Book</source>
          <person-group person-group-type="editor">
            <name>
              <surname>Foye</surname>
              <given-names>W.O.</given-names>
            </name>
          </person-group>
          <publisher-name>American Chemical Society</publisher-name>
          <publisher-loc>Washington, DC, USA</publisher-loc>
          <year>1995</year>
          <fpage>111</fpage>
          <lpage>121</lpage>
        </citation>
      </ref>
      <ref id="B2-molbank-2010-M651">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pongprom</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Mueller</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Spreitzer</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Carbinol derivatives of azanaphthoquinone annelated pyrrols</article-title>
          <source>Monatsh. Chem.</source>
          <year>2009</year>
          <volume>140</volume>
          <fpage>309</fpage>
          <lpage>313</lpage>
          <pub-id pub-id-type="doi">10.1007/s00706-008-0024-3</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2010-M651">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shanab</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Pongprom</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Wulz</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Spreitzer</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Aicher</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Mueller</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>G&#xFC;nther</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and biological evaluation of novel cytotoxic azanaphthoquinone annelated pyrrolo oximes</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2007</year>
          <volume>17</volume>
          <fpage>6091</fpage>
          <lpage>6095</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2007.09.054</pub-id>
          <pub-id pub-id-type="pmid">17904839</pub-id>
        </citation>
      </ref>
      <ref id="B4-molbank-2010-M651">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spreitzer</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Puschmann</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Dual function antitumor agents based on bioreduction and DNA-alkylation</article-title>
          <source>Monatsh. Chem.</source>
          <year>2007</year>
          <volume>138</volume>
          <fpage>517</fpage>
          <lpage>522</lpage>
          <pub-id pub-id-type="doi">10.1007/s00706-007-0604-7</pub-id>
        </citation>
      </ref>
      <ref id="B5-molbank-2010-M651">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haider</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Sotelo</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>1,5-Dimethyl-6H-pyridazino[4,5-b]carbazole, a 3-Aza bioisoster of the antitumor alkaloid olivacine</article-title>
          <source>Chem. Pharm. Bull.</source>
          <year>2002</year>
          <volume>50</volume>
          <fpage>1479</fpage>
          <lpage>1483</lpage>
          <pub-id pub-id-type="doi">10.1248/cpb.50.1479</pub-id>
          <pub-id pub-id-type="pmid">12419913</pub-id>
        </citation>
      </ref>
      <ref id="B6-molbank-2010-M651">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haider</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Kabicher</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>K&#xE4;ferb&#xF6;ck</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Plenk</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and <italic>in-vitro</italic> antitumor activity of 1-[3-(indol-1-yl)prop-1-yn-1-yl]phthalazines and related compounds</article-title>
          <source>Molecules</source>
          <year>2007</year>
          <volume>12</volume>
          <fpage>1900</fpage>
          <lpage>1909</lpage>
          <pub-id pub-id-type="doi">10.3390/12081900</pub-id>
          <pub-id pub-id-type="pmid">17960095</pub-id>
        </citation>
      </ref>
      <ref id="B7-molbank-2010-M651">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haider</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Jbara</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>K&#xE4;ferb&#xF6;ck</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Traar</surname>
              <given-names>U.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of tetra- and pentacyclic carbazole-fused imides as potential antitumor agents</article-title>
          <source>Arkivoc</source>
          <year>2009</year>
          <fpage>38</fpage>
          <lpage>47</lpage>
        </citation>
      </ref>
      <ref id="B8-molbank-2010-M651">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spreitzer</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Puschmann</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Regioselective alkylation of an oxonaphthalene-annelated pyrrol system</article-title>
          <source>Molbank</source>
          <year>2009</year>
          <fpage>M619</fpage>
          <pub-id pub-id-type="doi">10.3390/M619</pub-id>
        </citation>
      </ref>
      <ref id="B9-molbank-2010-M651">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spreitzer</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Puschmann</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Pichler</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Kogard</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Tschetschkowitsch</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Heinze</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Bauer</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Shabaz</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and NMR-investigation of annelated pyrrole derivatives</article-title>
          <source>Heterocycles</source>
          <year>1997</year>
          <volume>45</volume>
          <fpage>1989</fpage>
          <lpage>1997</lpage>
          <pub-id pub-id-type="doi">10.3987/COM-97-7877</pub-id>
        </citation>
      </ref>
      <ref id="B10-molbank-2010-M651">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spreitzer</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>F&#xFC;lep</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Puschmann</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title><italic>N</italic>-substituted 5,5-dimethyl-2,5-dihydro-4<italic>H</italic>-isoindol-4-ones: Synthesis and NMR-investigation</article-title>
          <source>Heterocycles</source>
          <year>1996</year>
          <volume>43</volume>
          <fpage>1911</fpage>
          <lpage>1922</lpage>
          <pub-id pub-id-type="doi">10.3987/COM-96-7510</pub-id>
        </citation>
      </ref>
      <ref id="B11-molbank-2010-M651">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brown</surname>
              <given-names>F.J.</given-names>
            </name>
            <name>
              <surname>Bernstein</surname>
              <given-names>P.R.</given-names>
            </name>
            <name>
              <surname>Cronk</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Dosset</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Hebbel</surname>
              <given-names>K.C.</given-names>
            </name>
            <name>
              <surname>Maduskuie</surname>
              <given-names>T.P.</given-names>
              <suffix>Jr.</suffix>
            </name>
            <name>
              <surname>Shapiro</surname>
              <given-names>H.S.</given-names>
            </name>
            <name>
              <surname>Vacek</surname>
              <given-names>E.P.</given-names>
            </name>
            <name>
              <surname>Yee</surname>
              <given-names>Y.K.</given-names>
            </name>
            <name>
              <surname>Willard</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Krell</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Snyder</surname>
              <given-names>D.W.</given-names>
            </name>
          </person-group>
          <article-title>Hydroxyacetophenone-derived antagonists of the peptidoleukotrienes</article-title>
          <source>J. Med. Chem.</source>
          <year>1989</year>
          <volume>32</volume>
          <fpage>807</fpage>
          <lpage>826</lpage>
          <pub-id pub-id-type="doi">10.1021/jm00124a014</pub-id>
          <pub-id pub-id-type="pmid">2704027</pub-id>
        </citation>
      </ref>
      <ref id="B12-molbank-2010-M651">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Palmer</surname>
              <given-names>B.D.</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>W.R.</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>R.F.</given-names>
            </name>
            <name>
              <surname>Boyd</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Denny</surname>
              <given-names>W.A.</given-names>
            </name>
          </person-group>
          <article-title>Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[N,N-Bis(2-chloroethyl)amino]-2,4-dinitrobenzamide</article-title>
          <source>J. Med. Chem.</source>
          <year>1996</year>
          <volume>39</volume>
          <fpage>2518</fpage>
          <lpage>2528</lpage>
          <pub-id pub-id-type="doi">10.1021/jm960057p</pub-id>
          <pub-id pub-id-type="pmid">8691449</pub-id>
        </citation>
      </ref>
      <ref id="B13-molbank-2010-M651">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meyer</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Regenass</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Fabbro</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Alteri</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>R&#xF6;sel</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>M&#xFC;ller</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Caravatti</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Matter</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and <italic>in vitro</italic> anti-proliferative as well as in vivo anti-tumor activity</article-title>
          <source>Int. J. Cancer</source>
          <year>1989</year>
          <volume>43</volume>
          <fpage>851</fpage>
          <lpage>856</lpage>
          <pub-id pub-id-type="doi">10.1002/ijc.2910430519</pub-id>
          <pub-id pub-id-type="pmid">2714889</pub-id>
        </citation>
      </ref>
      <ref id="B14-molbank-2010-M651">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nicolaou</surname>
              <given-names>K.C.</given-names>
            </name>
            <name>
              <surname>Scarpelli</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Bollbuck</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Werschkun</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Wartmann</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Altmann</surname>
              <given-names>K.H.</given-names>
            </name>
            <name>
              <surname>Zaharevitz</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Guscio</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Giannakakou</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Chemical synthesis and biological properties of pyridine epothilones</article-title>
          <source>Chem. Biol.</source>
          <year>2000</year>
          <volume>7</volume>
          <fpage>593</fpage>
          <lpage>599</lpage>
          <pub-id pub-id-type="doi">10.1016/S1074-5521(00)00006-5</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
